Business Wire

BITEPRO

Share
British Firm BitePRO Claim Education Professionals Are Bitten By Pupils On Daily Basis

According to British firm BitePRO , teachers and education professionals are at increased risk of being bitten by pupils and the consequences can be severe.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191015005707/en/

Human bites can more dangerous than animal bites because of the large quantity and types of bacteria and viruses contained in the human mouth. Human bites that break the skin can become severely infected.

According to several medical sources, human bites have been shown to transmit hepatitis B, hepatitis C, herpes simplex virus (HSV) syphilis, tuberculosis, actinomycosis, tetanus and even the human immunodeficiency virus (HIV).

Robert Kaiser, CEO of BitePRO a firm specialised in bite resistant clothing states: “We are fully aware of teachers working in special educational needs schools or units for pupils with severe mental and behavioural problems who were bitten so hard, so they had to be given vaccinations against infectious diseases and viruses such as Hepatitis B. Many also required immediate surgery.”

“Regrettably, there is still a culture in some schools, particularly where pupils have severe behavioural problems, that being assaulted is all part of the job.”

Recently, teachers seem to talk openly about their daily experiences of being bitten, and their visits to hospitals. This is most certainly the case.

Brett Bigham, Oregon’s Teacher of the Year in 2014 reported to have been bitten so badly that he was sent to the hospital.

In October 2019 a Canberra public school worker was repeatedly bitten by one of her students. She was injured on a weekly basis, for six months, by a child with a mental disability. In an interview with local media she stated: “"I was bitten on the arms; I was bitten on the stomach and I was bitten on the leg. That was day one."

The ‘News and Features from the National Education Association’ admitted or rather stated on the 20 June 2019 that many teachers, administrators, and education support professionals (ESPs) are at risk of being bitten while at work.

Educational professionals around the world are now rightly calling for greater protection from children who bite them. Human teeth breaking their skin and leading to serious injury, infections, long term trauma and require complex surgery cannot be part of their daily routine.

Many have now walked away from a profession they were once extremely passionate about, because medical experts have been able to identify that they suffer from PTSD (Post Traumatic Stress Disorder), an illness, usually associated to soldiers returning from wars, having witnessed severe levels of violence.

According to Robert Kaiser, bite resistant arm guards might not change the behaviour of violent children, or the behaviour of children diagnosed with specific mental illnesses. But there is no question about it, such type of highly protective clothing will reduce the risk of injury and infections. It will prevent immense long-term emotional distress to teachers. It will help them to continue working within a sector they are passionate about.

Kayleigh Davis, Senior Consultant at BitePRO is also keen to point out some vital legal information: “Today’s legal environment will require a risk assessment to be conducted, highlighting any realistic risk employees are being exposed to e.g. being bitten by a pupil.”

“The purpose of such is to very clearly identifying a) the precise risk, b) the potential liability and c) the implementation of effective mitigating measures. I believe that BitePRO should be considered as one of many mitigations measures you can utilise and implement to reduce a realistic risk faced by today’s educational professionals.”

“Failing to do so can ultimately result in liability claims and legal action being taken against your organisation by either an injured employee or indeed an overseeing government body.”

The Portland Tribune reported on 01 February 2019 that eight educational assistants are suing Portland Public Schools and several administrators for $3.6 million alleging the special needs students they were supposed to assist frequently assaulted them by biting and scratching etc. The lawsuit accused the district partly of negligence. The lawsuit claimed the district and administrators did not sufficiently protect the educational assistants or students.

The fact of the matter is a school and any other educational facility is required to provide a safe and healthy workplace: It is not optional. It is the law.

For any product related questions, please email info@bite-pro.com .

### END

About BitePRO:

The BitePRO brand is part of PPSS Group’s global operation. PPSS Group is specialised in the development, manufacturing and supply of high-performance personal protective equipment, offering unrivalled protection from edged weapons, blunt force trauma and even human bites. Please follow BitePRO on social media: Facebook , LinkedIn , Twitter and Instagram .

Link:

ClickThru

Social Media:

https://www.facebook.com/biteproclothing/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse

Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release

Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye